Beth Van Duyne addresses FDA decision on thyroid medication and tax policy discussion
Congresswoman Beth Van Duyne posted about her advocacy for continued patient access to Desiccated Thyroid Extract following recent FDA actions and discussed tax policy during a media panel appearance.
